Analyzing the Distinctive Market Performance and Regulatory Landscape of Imatinib Across Major Geographies: Understanding the Imatinib Drug Market Regional Share The distribution of the Imatinib Drug Market’s revenue and unit sales exhibits pronounced regional variations, largely influenced by healthcare expenditure, cancer incidence rates, and regulatory frameworks surrounding generic drugs. North America historically commanded the largest market share, driven by high treatment costs and advanced healthcare infrastructure that facilitated early and broad adoption of the branded drug, Gleevec. However, with the advent of generics post-patent expiry, this region’s market value has faced pressure, although it maintains Ref - https://www.marketresearchfuture.com/reports/imatinib-drug-market-42762